OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis $2.35 0.00 (0.00%) As of 10/2/2024 Add Compare Share Share Stock Analysis Stock Analysis About Augmedix Stock (OTCMKTS:AUGX) Get Augmedix alerts:Sign Up Key Stats Today's Range$2.35▼$2.3550-Day Range$2.35▼$2.3552-Week Range$0.73▼$6.25VolumeN/AAverage Volume635,746 shsMarket Capitalization$115.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Augmedix is a healthcare technology company that develops tools designed to reduce the administrative burden associated with clinical documentation. Its platform uses artificial intelligence, natural language processing and, historically, remote medical scribe support to help convert clinician-patient conversations into structured medical notes and other documentation. The company’s offerings have included Augmedix Ambient AI, which captures and summarizes clinical encounters, as well as products and services intended to support medical note creation, workflow management and integration with electronic health record systems. Augmedix has marketed its solutions to healthcare providers and organizations, primarily in the United States, across areas such as primary care, emergency medicine and specialty care. Founded in 2012, Augmedix was headquartered in San Francisco and was led for much of its public-company period by Chief Executive Officer Manny Krakaris. Commure announced an agreement to acquire Augmedix in 2024, and the transaction was subsequently completed. As a result, information associated with Augmedix and the OTC Markets symbol AUGX may reflect its historical status as a publicly traded company rather than an independently operating public issuer.AI Generated. May Contain Errors. Read More Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AUGX Stock News HeadlinesAugmedix Delivers 27% Revenue Growth for Second Quarter of 2024June 10, 2026 | stockhouse.comLake Street Downgrades Augmedix (AUGX)July 23, 2024 | msn.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 26 at 1:00 AM | Profits Run (Ad)SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Augmedix, Inc. BuyoutJuly 22, 2024 | stockhouse.comAugmedix Agrees to $139 Million Acquisition by CommureJuly 19, 2024 | marketwatch.comAUGX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Augmedix, Inc. Is Fair to ShareholdersJuly 19, 2024 | tmcnet.comAI-Focused Healthcare Documentation Provider Augmedix Goes Private In $139M DealJuly 19, 2024 | msn.comAugmedix to be acquired by Commure in transaction valuing the former at ~$139MJuly 19, 2024 | msn.comSee More Headlines AUGX Stock Analysis - Frequently Asked Questions How have AUGX shares performed this year? Augmedix's stock was trading at $2.35 at the start of the year. Since then, AUGX stock has increased by 0.0% and is now trading at $2.35. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) issued its quarterly earnings results on Monday, March, 27th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. The firm had revenue of $8.75 million for the quarter, compared to the consensus estimate of $8.52 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%. How do I buy shares of Augmedix? Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Augmedix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include Meta Platforms (META), Urban Outfitters (URBN), Arista Networks (ANET), Capital Southwest (CSWC), NVIDIA (NVDA), PACCAR (PCAR) and Turkcell Iletisim Hizmetleri AS (TKC). Company Calendar Last Earnings3/27/2023Today9/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolOTCMKTS:AUGX CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees710Year Founded2012Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$24.45 million Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$51.58 million Price / Sales2.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book23.50Miscellaneous Outstanding Shares48,968,000Free Float36,316,000Market Cap$115.07 million OptionableNot Optionable Beta-0.22 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:AUGX) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredDid you forget to grab this?Most beginners stay stuck on the sidelines for years because no one shows them the simple steps between being ...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AUGX Stock Alerts